IP Library Granted Patent US 10,245,105
Granted Patent B2
US 10,245,105 · App. 14/627,046 · Granted Apr 2, 2019

Electroporation with cooling to treat tissue

Inventors: Rafael V. Davalos (Blacksburg, VA); Paulo A. Garcia (Cambridge, MA); John L. Robertson (Floyd, VA); John H. Rossmeisl (Blacksburg, VA); Robert E. Neal, II (Richmond, VA)
Assignee: VIRGINIA TECH INTELLECTUAL PROPERTIES, INC.
A61B18/1477A61B18/1206A61N1/327C12N13/00A61B2018/00446A61B2018/00613A61N1/05
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,245,105
App. No.
14/627,046
Granted
Apr 2, 2019
Kind
B2
Abstract

The present invention provides methods, devices, and systems for in vivo treatment of cell proliferative disorders. Included is a method of treating tissue with electrical energy, the method comprising: delivering electrical energy to tissue using one or more electroporation devices comprising one or more electrodes; and cooling the tissue, surrounding tissue, one or more of the electrodes, or one or more of the electroporation devices to minimize heating. In embodiments, the invention can be used to treat solid tumors, such as brain tumors, and in some embodiments, exemplary methods rely on non-thermal irreversible electroporation (IRE) to cause cell death in treated tumors.

Claims (28)

1. A method of treating tissue with electrical energy, the method comprising:

performing electroporation of target tissue using one or more electroporation devices comprising one or more electrodes and one or more hollow chambers with a fluid disposed therein; and

flowing the fluid disposed in one or more of the hollow chambers to provide cooling during the electroporation to cause non-thermal cell death of the target tissue.

2. The method of claim 1 , wherein the electroporation causes non-thermal irreversible electroporation of cells.

3. The method of claim 1 , wherein the electroporation devices are chosen from one or more bipolar or monopolar probes.

4. The method of claim 1 , wherein the cooling is provided at an electrode-tissue interface.

5. The method of claim 1 , wherein the electroporation is performed in a manner to avoid thermal damage to target tissue and non-target tissue.

6. The method of claim 1 , wherein the cooling is provided by circulating the fluid through one or more of the hollow chambers.

7. The method of claim 1 , wherein one or more of the hollow chambers is disposed along a center axis of one or more of the electroporation devices.

8. A method of treating tissue with electrical energy, the method comprising:

delivering electrical energy to target tissue to cause non-thermal irreversible electroporation (IRE) of cells using one or more electroporation devices comprising one or more electrodes and one or more hollow chambers with a fluid disposed therein; and

flowing the fluid disposed in one or more of the hollow chambers to provide for cooling at an electrode-tissue interface.

9. The method of claim 8 , wherein the electroporation devices are chosen from one or more bipolar or monopolar probes.

10. The method of claim 8 , wherein the IRE is performed in a manner to avoid thermal damage to target tissue and non-target tissue.

11. The method of claim 8 , wherein one or more of the hollow chambers is disposed along a center axis of one or more of the electroporation devices.

12. The method of claim 8 , wherein the cooling is provided by circulating the fluid through one or more of the hollow chambers.

13. A method of treating tissue with electrical energy, the method comprising:

delivering electrical energy to target tissue using one or more electroporation devices comprising:

at least two electrodes disposed as annular conductive surfaces along an axis of a single probe; and

one or more hollow chambers with a fluid disposed therein;

wherein the delivering of the electrical energy to the target tissue comprises alternating polarity of the at least two electrodes;

flowing the fluid disposed in one or more of the hollow chambers to provide for cooling during the delivering to result in non-thermal cell death within the target tissue.

14. The method of claim 13 , wherein the delivering of the electrical energy causes non-thermal irreversible electroporation (IRE) of cells.

15. The method of claim 13 , wherein the cooling is provided at an electrode-tissue interface.

16. The method of claim 13 , wherein the delivering of the electrical energy is performed in a manner to avoid thermal damage to target tissue and non-target tissue.

17. The method of claim 13 , wherein the cooling is provided by circulating the fluid through one or more of the hollow chambers.

18. The method of claim 13 , wherein one or more of the hollow chambers is disposed along a center axis of one or more of the electroporation devices.

19. The method of claim 13 , wherein a non-conductive surface is disposed between the two annular conductive surfaces.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2015
From: DAVALOS, RAFAEL V.; GARCIA, PAULO A.; ROBERTSON, JOHN L.; ROSSMEISL, JOHN H.; NEAL, ROBERT E.
To: VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY
Reel/Frame 035072/0052 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2015
From: VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY
To: VIRGINIA TECH INTELLECTUAL PROPERTIES, INC.
Reel/Frame 035072/0068 →
Continuity (7)
Continuation 12491151 · Jun 24, 2009
Continuation In Part 12432295 · Apr 29, 2009
Provisional Application 61125840 · Apr 29, 2008
Provisional Application 61171564 · Apr 22, 2009
Provisional Application 61167997 · Apr 9, 2009
Provisional Application 61075216 · Jun 24, 2008
Related Publication 20150164584A1 · Jun 18, 2015
Cited By (16)
US 12,186,011 US 12,201,349 US 12,214,189 US 12,232,792 US 12,239,365 US 12,349,967 US 12,390,262 US 12,390,268 US 12,403,305 US 12,426,948 US 12,484,963 US 12,485,279 US 12,575,879 US 12,685,578 US 12,697,172 US 12,708,766